-
effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-fecal-incontinence_10.pdf
October 26, 2020 - -2
3 or/1-2 (7262)
4 exp *Therapeutics/ (2522988)
5 (biofeedback or device* or diet* or drug or drugs … (anal or fecal or faecal) adj incontinen*).ti. (584)
2 (biofeedback or device* or diet* or drug or drugs … ((anal or fecal or faecal) adj incontinen*).ti. (15)
2 (biofeedback or device* or diet* or drug or drugs … incontinence OR fecal incontinence OR faecal incontinence ) AND ( biofeedback OR
device OR diet OR drug OR drugs … OR+f
ecal+incontinence+OR+faecal+incontinence+%29+AND+%28+biofeedback+OR
+device+OR+diet+OR+drug+OR+drugs
-
effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-fecal-incontinence_9.pdf
October 26, 2020 - -2
3 or/1-2 (7262)
4 exp *Therapeutics/ (2522988)
5 (biofeedback or device* or diet* or drug or drugs … (anal or fecal or faecal) adj incontinen*).ti. (584)
2 (biofeedback or device* or diet* or drug or drugs … ((anal or fecal or faecal) adj incontinen*).ti. (15)
2 (biofeedback or device* or diet* or drug or drugs … incontinence OR fecal incontinence OR faecal incontinence ) AND ( biofeedback OR
device OR diet OR drug OR drugs … OR+f
ecal+incontinence+OR+faecal+incontinence+%29+AND+%28+biofeedback+OR
+device+OR+diet+OR+drug+OR+drugs
-
effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-fecal-incontinence_8.pdf
October 26, 2020 - -2
3 or/1-2 (7262)
4 exp *Therapeutics/ (2522988)
5 (biofeedback or device* or diet* or drug or drugs … (anal or fecal or faecal) adj incontinen*).ti. (584)
2 (biofeedback or device* or diet* or drug or drugs … ((anal or fecal or faecal) adj incontinen*).ti. (15)
2 (biofeedback or device* or diet* or drug or drugs … incontinence OR fecal incontinence OR faecal incontinence ) AND ( biofeedback OR
device OR diet OR drug OR drugs … OR+f
ecal+incontinence+OR+faecal+incontinence+%29+AND+%28+biofeedback+OR
+device+OR+diet+OR+drug+OR+drugs
-
effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-fecal-incontinence_7.pdf
October 26, 2020 - -2
3 or/1-2 (7262)
4 exp *Therapeutics/ (2522988)
5 (biofeedback or device* or diet* or drug or drugs … (anal or fecal or faecal) adj incontinen*).ti. (584)
2 (biofeedback or device* or diet* or drug or drugs … ((anal or fecal or faecal) adj incontinen*).ti. (15)
2 (biofeedback or device* or diet* or drug or drugs … incontinence OR fecal incontinence OR faecal incontinence ) AND ( biofeedback OR
device OR diet OR drug OR drugs … OR+f
ecal+incontinence+OR+faecal+incontinence+%29+AND+%28+biofeedback+OR
+device+OR+diet+OR+drug+OR+drugs
-
effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-fecal-incontinence_5.pdf
October 26, 2020 - -2
3 or/1-2 (7262)
4 exp *Therapeutics/ (2522988)
5 (biofeedback or device* or diet* or drug or drugs … (anal or fecal or faecal) adj incontinen*).ti. (584)
2 (biofeedback or device* or diet* or drug or drugs … ((anal or fecal or faecal) adj incontinen*).ti. (15)
2 (biofeedback or device* or diet* or drug or drugs … incontinence OR fecal incontinence OR faecal incontinence ) AND ( biofeedback OR
device OR diet OR drug OR drugs … OR+f
ecal+incontinence+OR+faecal+incontinence+%29+AND+%28+biofeedback+OR
+device+OR+diet+OR+drug+OR+drugs
-
effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-fecal-incontinence_6.pdf
October 26, 2020 - -2
3 or/1-2 (7262)
4 exp *Therapeutics/ (2522988)
5 (biofeedback or device* or diet* or drug or drugs … (anal or fecal or faecal) adj incontinen*).ti. (584)
2 (biofeedback or device* or diet* or drug or drugs … ((anal or fecal or faecal) adj incontinen*).ti. (15)
2 (biofeedback or device* or diet* or drug or drugs … incontinence OR fecal incontinence OR faecal incontinence ) AND ( biofeedback OR
device OR diet OR drug OR drugs … OR+f
ecal+incontinence+OR+faecal+incontinence+%29+AND+%28+biofeedback+OR
+device+OR+diet+OR+drug+OR+drugs
-
effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-fecal-incontinence_4.pdf
October 26, 2020 - -2
3 or/1-2 (7262)
4 exp *Therapeutics/ (2522988)
5 (biofeedback or device* or diet* or drug or drugs … (anal or fecal or faecal) adj incontinen*).ti. (584)
2 (biofeedback or device* or diet* or drug or drugs … ((anal or fecal or faecal) adj incontinen*).ti. (15)
2 (biofeedback or device* or diet* or drug or drugs … incontinence OR fecal incontinence OR faecal incontinence ) AND ( biofeedback OR
device OR diet OR drug OR drugs … OR+f
ecal+incontinence+OR+faecal+incontinence+%29+AND+%28+biofeedback+OR
+device+OR+diet+OR+drug+OR+drugs
-
effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-fecal-incontinence_3.pdf
October 26, 2020 - -2
3 or/1-2 (7262)
4 exp *Therapeutics/ (2522988)
5 (biofeedback or device* or diet* or drug or drugs … (anal or fecal or faecal) adj incontinen*).ti. (584)
2 (biofeedback or device* or diet* or drug or drugs … ((anal or fecal or faecal) adj incontinen*).ti. (15)
2 (biofeedback or device* or diet* or drug or drugs … incontinence OR fecal incontinence OR faecal incontinence ) AND ( biofeedback OR
device OR diet OR drug OR drugs … OR+f
ecal+incontinence+OR+faecal+incontinence+%29+AND+%28+biofeedback+OR
+device+OR+diet+OR+drug+OR+drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tinnitus_executive.pdf
August 01, 2013 - Five articles12-16
investigated antidepressant drugs versus placebo. … These
drugs included sertraline,12,13 paroxetine,14 trazodone,15
and nortriptyline.16 Dosage levels … The neurotransmitter drugs were gabapentin,17 baclofen,18
alprazolam,19 and acamprosate.20,21 Three … studies
investigated other drugs, including methylprednisolone
versus placebo,22 vardenafil versus … , food
supplements, and other
drugs
Evidence suggests that neurotransmitter drugs showed
improvement
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine-1_research.pdf
February 01, 2009 - Annual age-specific utilization of DMARDs, glucocorticoids, non-steroidal anti-
inflammatory drugs (NSAIDs … rheumatoid arthritis, disease modifying anti-rheumatic drugs, epidemiology
Effective Health Care … 8
Introduction
The treatment of rheumatoid arthritis (RA) with disease modifying anti-rheumatic drugs … Interestingly, about 10% of patients were not using any study drugs on
the index dates. … The changing
use of disease-modifying anti-rheumatic drugs in
individuals with rheumatoid arthritis
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/diagnosis-and-treatment-of-low-back-painbr-key-questionsbr-olliin-patients-with-low-back-pain-what-are-the-benefits-and-harms-of-identifying-risk-factors-for-chronicity-and-targeting-treatment-based-on-assessed-riskliliin-pat
March 11, 2013 - joint steroid injection, intradiscal methylene blue, intradiscal ozone, injections involving anti-TNF drugs … yes
If yes, explain the specific technologies, devices, drugs, or interventions you would like to
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-patients-with-pku-there-is-now-a-pharmaceutical-drug-to-treat-this-condition-in-the-past-is-was-treated-by-medical-foods-that-eliminated-the-harmful-substance-phenylalanine-the-cost-of-the-new-drug-is-70k-year-the-cost-to
June 17, 2009 - yes
If yes, explain the specific technologies, devices, drugs, or interventions you would like to … All drugs have side effects. Medical foods do not.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_disposition-comments.pdf
September 01, 2011 - A few years ago, these drugs were all off label for autism, depression,
augmentation of depression, … Actually, we refrained from
doing pooled analyses across,
drugs in response to reviewers
comments … So, we think the
report is suitably restrained on
drawing conclusions across
drugs. … As these drugs are
approved for use in MDD, rationale for inclusion of the data in the report should … The drugs
are still included in the
chart for comparative
purposes.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine-update_research-protocol.pdf
May 15, 2017 - Newly approved drugs and those under review by the FDA are described in Section B
(see Table 1) above … Few data are available on efficacy for these drugs; even less is
known about how their effectiveness … and harms compared with that of existing drugs. … What has Changed
New drugs: Additional clinical trials of three biosimilar drugs and a tsDMARD (an … Clinical trials of new drugs
for the treatment of rheumatoid arthritis: focus on early disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_disposition-comments.pdf
November 27, 2012 - , just as non-
biologics for psoriasis are not considered a “class” of drugs either. … We have added
the terms biologic and nonbiologic to our
glossary with a listing of the drugs which … Suggest specifically mentioning the nonbiologic drugs. Thank you for this suggestion. … Are they
naïve to both drugs (mtx, adalimumab, etanercept?)
Thank you for this suggestion. … More information about each of the drugs
and phototherapy would be helpful.
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia_horizon-scan-high_impact-1306-revised.pdf
July 09, 2013 - In the health care sector, horizon
scanning pertains to identifying new (and new uses of existing) pharmaceuticals … Information is compiled for expert comment on topics at a
granular level (i.e., similar drugs in the … The search is on for ways to definitively diagnose AD and for drugs, biologics, and alternative
or … The Horizon Scanning System is tracking several
drugs in late-phase development. … Peripheral and Central Nervous System Drugs
Advisory Committee.
-
effectivehealthcare.ahrq.gov/sites/default/files/11_peptic_ulcer_potential_high_impact_2012-12-111.pdf
January 01, 2012 - Bedminster (NJ): NPS
Pharmaceuticals, Inc.; 2011 May 12 [accessed
2011 Jul 15]. [2 p]. … Bedminster (NJ):
NPS Pharmaceuticals, Inc.; 2011 Oct 31
[accessed 2011 Nov 11]. [4 p]. … Bedminster (NJ): NPS
Pharmaceuticals, Inc.; 2012 Oct 16 [accessed
2012 Oct 16]. [3 p]. … Bedminster (NJ): NPS
Pharmaceuticals, Inc.; 2012 Jan 31 [accessed
2012 Jun 5]. [2 p]. … Bedminster (NJ): NPS Pharmaceuticals, Inc.;
2011 Dec 1 [accessed 2012 Jan 26]. [2 p].
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/schizophrenia-adult_research-protocol.pdf
September 23, 2016 - Second-Generation Antipsychotic Drugs
Aripiprazole (Abilify®, Aristada™*)
Asenapine (Saphris® ), … and in 2013 for 2nd versus 2nd
generation drugs. … Consensus development conference on antipsychotic drugs and
obesity and diabetes. … Drug Class Review of Atypical Antipsychotic Drugs;
Update 3. … Drug Class Review: Second Generation Antipsychotic
Drugs. Final Report - Update 4.
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-215-depression-older-adults-comments.pdf
March 28, 2019 - We have listed
the included drugs and also how they
were decided upon. … Only studies that
evaluated one of the drugs in Table 1
were eligible. … These drugs could have
been in comparison to a TCA. … to
meaningfully compare drugs in this class and assess their
relative harms. … Thus, it is incorrect to claim
that drugs does not cause adverse events based on public
data.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-comments.pdf
March 28, 2019 - We have listed
the included drugs and also how they
were decided upon. … Only studies that
evaluated one of the drugs in Table 1
were eligible. … These drugs could have
been in comparison to a TCA. … to
meaningfully compare drugs in this class and assess their
relative harms. … Thus, it is incorrect to claim
that drugs does not cause adverse events based on public
data.